DrugApr 17, 2013
Portia recall — FDA D-245-2013
Failed Tablet/Capsule Specifications: This recall is being carried out due to an out of specification result for appearance.
Class IIIFDA: TerminatedTeva Pharmaceuticals USA, Inc.
Recall history in this database
Classification mix: Class II: 37, Class III: 17, Class I: 1.
DrugApr 10, 2013
Teva Pharmaceuticals USA CLONAZEPAM ORALLY DISINTERGRATING Tablets, USP, 0.5 mg, 60 tablets recall — FDA D-237-2013
Failed Content Uniformity Specifications: Recall is being carried out due to an out-of-specification result for content uniformity.
Class IIFDA: TerminatedTeva Pharmaceuticals USA, Inc.
DrugMar 20, 2013
Teva Pharmaceuticals USA Terazosin Hydrochloride Capsules, 2 mg recall — FDA D-193-2013
Presence of Foreign Tablets/Capsules: Recall is being conducted due to a foreign capsule found in one bottle.
Class IIFDA: TerminatedTeva Pharmaceuticals USA, Inc.
DrugJul 11, 2012
Teva Pharmaceuticals USA Metoprolol Tartrate Tablets USP 50 mg, 1000 count bottle recall — FDA D-1409-2012
Tablet Thickness: Potential for some tablets not conforming to weight specifications (under and over weight)
Class IIFDA: TerminatedTeva Pharmaceuticals USA, Inc.
DrugJul 4, 2012
Teva Pharmaceuticals USA Zeosa recall — FDA D-1397-2012
Impurities/Degradation: This recall is being carried out due to the potential for some lots not meeting impurity specifications.
Class IIFDA: TerminatedTeva Pharmaceuticals USA, Inc.
DrugJul 4, 2012
Mefloquine HCL Tablets, 250 mg, 5 tablets per blister pack recall — FDA D-1396-2012
Tablet Thickness: Product is being recalled due to the potential of being underweight or overweight.
Class IIFDA: TerminatedTeva Pharmaceuticals USA, Inc.
DrugJun 27, 2012
Jolessa recall — FDA D-1384-2012
Contraceptive Tablets Out of Sequence: This recall has been initiated due to the potential that some regimen packages may not contain placebo tablets.
Class IIIFDA: TerminatedTeva Pharmaceuticals USA, Inc.
Understanding this recall history
This page summarizes recall records in which the official source identifies Teva Pharmaceuticals USA, Inc. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.